Did you mean 1000 20 6?
Displaying drugs 76 - 100 of 4712 in total
Ibandronate
Ibandronate, or BM 21.0955, is a third generation, nitrogen containing bisphosphonate similar to zoledronic acid, minodronic acid, and risedronic acid.[A203111,A203138] It is used to prevent and treat postmenopausal osteoporosis.[L13805,L13808] Ibandronate was first described in the literature in 1993 as a treatment for bone loss in dogs. Ibandronate was granted FDA...
Approved
Investigational
Matched Products: … OSIBAN 6 MG/6 ML IV INF. ICIN KON. COZ. ICEREN FLAKON ... BONDRONAT 6 MG/6 ML IV İNFÜZYONLUK KONSANTRE ÇÖZELTİ, 1 ADET ... BONDRONAT 6 MG/6 ML IV İNFÜZYONLUK KONSANTRE ÇÖZELTİ, 5 ADET …
Busulfan
Busulfan is a bifunctional alkylating agent, having a selective immunosuppressive effect on bone marrow. It is not a structural analog of the nitrogen mustards. It has been used in the palliative treatment of chronic myeloid leukemia (myeloid leukemia, chronic), but although symptomatic relief is provided, no permanent remission is brought...
Approved
Investigational
Matched Products: … BUSULTU 6 MG/ML IV İNFÜZYON İÇİN KONSANTRE ÇÖZELTİ, 1 ADET ... BUSILVEX 6 MG/ML IV İNFÜZYON İÇİN KONSANTRE ÇÖZELTİ, 1 ADET ... Busulfan Accord 6 mg/ml Konzentrat zur Herstellung einer Infusionslösung …
Butylscopolamine
Butylscopolamine is a peripherally acting antimuscarinic, anticholinergic agent. It is used to treat pain and discomfort caused by abdominal cramps, menstrual cramps, or other spasmodic activity in the digestive system. It is also effective at preventing bladder spasms. It is not a pain medication in the normal sense, since it...
Approved
Investigational
Vet approved
Matched Products: … SKOPOLIN AMPUL, 6 ADET ... SPAZMOTEK SUPOZITUAR, 6 ADET ... ENJEKSİYONLUK ÇÖZELTİ İÇEREN AMPUL, 6 AMPUL …
Sulfamethazine
A sulfanilamide anti-infective agent. It has a spectrum of antimicrobial action similar to other sulfonamides.
Approved
Investigational
Vet approved
Matched Synonyms: … 6-(4'-Aminobenzol-sulfonamido)-2,4-dimethylpyrimidin …
Etelcalcetide
Etelcalcetide is a calcimimetic drug for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis. Etelcalcetide was approved (trade name Parsabiv) for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis in February, 2017.
Approved
Investigational
Matched Salts cas: … 1334237-71-6 …
Matched Products: … ENJEKSİYONLUK ÇÖZELTİ, 6 ADET ... ENJEKSİYONLUK ÇÖZELTİ, 6 ADET ... ENJEKSİYONLUK ÇÖZELTİ, 6 ADET …
Matched Products: … ENJEKSİYONLUK ÇÖZELTİ, 6 ADET ... ENJEKSİYONLUK ÇÖZELTİ, 6 ADET ... ENJEKSİYONLUK ÇÖZELTİ, 6 ADET …
Telmisartan
Telmisartan is an angiotensin II receptor antagonist (ARB) used in the management of hypertension. Generally, angiotensin II receptor blockers (ARBs) such as telmisartan bind to the angiotensin II type 1 (AT1) receptors with high affinity, causing inhibition of the action of angiotensin II on vascular smooth muscle, ultimately leading to...
Approved
Investigational
Matched Synonyms: … 4'-((4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid …
Matched Iupac: … 4'-{[4-methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-benzodiazol-1-yl]methyl}-[1,1'-biphenyl …
Matched Iupac: … 4'-{[4-methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-benzodiazol-1-yl]methyl}-[1,1'-biphenyl …
Mirikizumab
Mirikizumab is a monoclonal antibody developed by Eli Lilly intended to treat ulcerative colitis. It inhibits the actions of interleukin-23 (IL-23), a pro-inflammatory cytokine that activates pathways contributing to the development of inflammatory diseases.[L46237,L46257]
Mirikizumab is approved in Japan and received a positive opinion from the EMA's Committee for Medicinal...
Approved
Investigational
Matched Description: … It inhibits the actions of interleukin-23 (IL-23), a pro-inflammatory cytokine that activates pathways …
Matched Categories: … Interleukin-23 Antagonist …
Matched Categories: … Interleukin-23 Antagonist …
Azelastine
Azelastine, a phthalazine derivative, is an antihistamine available as an intranasal spray for the treatment of allergic and vasomotor rhinitis and as an ophthalmic solution for the treatment of allergic conjunctivitis.[L8240,L8270] It is a racemic mixture, though there is no noted difference in pharmacologic activity between enantiomers, and was first...
Approved
Matched Description: … Dymista™, which is indicated for the symptomatic treatment of seasonal allergic rhinitis in patients 6 …
Matched Mixtures name: … DYMİSTA 137 MCG + 50 MCG BURUN SPREYİ, SÜSPANSİYON, 23 G …
Matched Products: … ZELASS-M % 0.05 GÖZ DAMLASI,6 ML ... ALLERGODİL %0,05 GÖZ DAMLASI, ÇÖZELTİ, 6 ML …
Matched Mixtures name: … DYMİSTA 137 MCG + 50 MCG BURUN SPREYİ, SÜSPANSİYON, 23 G …
Matched Products: … ZELASS-M % 0.05 GÖZ DAMLASI,6 ML ... ALLERGODİL %0,05 GÖZ DAMLASI, ÇÖZELTİ, 6 ML …
Betahistine
Ménière's disease is a progressive disease of the inner ear characterized by vertigo, tinnitus, and hearing loss. It has a significant impact on both the physical and social functioning of affected individuals.[A220318,L16408]
Betahistine is a histamine-like antivertigo drug used for treating symptoms associated with Ménière's disease. It is thought to...
Approved
Investigational
Matched Salts cas: … 54856-23-4 …
Matched Products: … HISTIGEN 6 ... เบตาฮีส 6 ... เมอซัน - 6 …
Matched Products: … HISTIGEN 6 ... เบตาฮีส 6 ... เมอซัน - 6 …
Tildrakizumab
Tildrakizumab is a high-affinity, humanized, IgG1 κ antibody targeting interleukin 23 p19 that shows promise in the evolution of treatment strategy in chronic plaque psoriasis .
The Food and Drug Administration (FDA) approved ILUMYA (tildrakizumab-asmn) for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy...
Approved
Investigational
Matched Description: … Tildrakizumab is a high-affinity, humanized, IgG1 κ antibody targeting interleukin 23 p19 that shows …
Matched Categories: … Interleukin-23 Antagonist ... Interleukin-23 Subunit p19 …
Matched Categories: … Interleukin-23 Antagonist ... Interleukin-23 Subunit p19 …
Guselkumab
Guselkumab is a human immunoglobulin G1 lambda (IgG1λ) monoclonal antibody that selectively blocks interleukin-23. IL-23 is an inflammatory cytokine that activates the CD4+ T-helper (Th17) cell pathway to mediate the inflammatory cascade that induces psoriatic plaque formation . In clinical trials, guselkumab demonstrated improved skin clearance and symptomatic improvements in...
Approved
Investigational
Matched Description: … is a human immunoglobulin G1 lambda (IgG1λ) monoclonal antibody that selectively blocks interleukin-23 ... IL-23 is an inflammatory cytokine that activates the CD4+ T-helper (Th17) cell pathway to mediate the …
Matched Categories: … Interleukin-23 Antagonist ... Interleukin-23 Subunit p19 …
Matched Categories: … Interleukin-23 Antagonist ... Interleukin-23 Subunit p19 …
Tolfenamic acid
Tolfenamic acid, with the formula N-(2-methyl-3-chlorphenyl)-anthranilic acid, is a nonsteroidal anti-inflammatory agent. It was discovered by scientists at Medica Pharmaceutical Company in Finland. It is used in the UK as a treatment for migraine under the name of Clotam. In the US, it presents a Status class I by the...
Approved
Investigational
Matched Products: … TOLFEDINE TABLETS 6 MG …
Glimepiride
First introduced in 1995, glimepiride is a member of the second-generation sulfonylurea (SU) drug class used for the management of type 2 diabetes mellitus (T2DM) to improve glycemic control. Type 2 diabetes is a metabolic disorder with increasing prevalences worldwide; it is characterized by insulin resistance in accordance with progressive...
Approved
Matched Products: … Amaryl 6 mg Tabletten ... AMARYL 6 MG TABLET, 30 ADET ... AMARYL 6 MG TABLET, 90 ADET …
Formoterol
Formoterol is an inhaled beta2-agonist used in the management of COPD and asthma that was first approved for use in the United States in 2001. It acts on bronchial smooth muscle to dilate and relax airways, and is administered as a racemic mixture of its active (R;R)- and inactive (S;S)-enantiomers....
Approved
Investigational
Matched Mixtures name: … BUDEK PLUS® 200/6 MCG ... FOSTER NEXTHALER 200/6 ... FOSTER NEXTHALER 200/6 …
Matched Products: … Oxis Turbohaler 6 µg - Dosier-Pulverinhalator ... AEROFOR 6 MCG İNHALASYON İÇİN TOZ İÇEREN BLİSTER, 60 DOZ ... FORMODAY 6 MCG INHALASYON ICIN TOZ ICEREN KAPSUL, 60 ADET …
Matched Products: … Oxis Turbohaler 6 µg - Dosier-Pulverinhalator ... AEROFOR 6 MCG İNHALASYON İÇİN TOZ İÇEREN BLİSTER, 60 DOZ ... FORMODAY 6 MCG INHALASYON ICIN TOZ ICEREN KAPSUL, 60 ADET …
Dinutuximab
Dinutuximab is an IgG1 monoclonal human/mouse chimeric antibody against GD2, a disialoganglioside expressed on tumors of neuroectodermal origin, including human neuroblastoma and melanoma, with highly restricted expression on normal tissues. It is composed of the variable heavy- and light-chain regions of the murine anti-GD2 mAb 14.18 and the constant regions...
Approved
Investigational
Pamidronic acid
Pamidronic acid is a second generation, nitrogen containing bisphosphonate similar to neridronic acid and alendronic acid. Pamidronic acid was first described in the literature in 1977. The second generation bisphosphonates are less common as third generation bisphosphonates, such as ibandronic acid, zoledronic acid, minodronic acid, and risedronic acid are becoming...
Approved
Matched Products: … Pamidronate Disodium Omega 6 mg/ml ... Pamidronat Dinatrium Pfizer 6 mg/ml, Konzentrat zur Herstellung einer Infusionslösung …
Pyrantel
Pyrantel is a pyrimidine-derivative anthelmintic agent for the oral treatment of various parasitic worm infections including ascariasis, hookworm infections, enterobiasis (pinworm infection), trichostrongyliasis, and trichinellosis .
Pyrantel was initially described in 1965 by researchers from Pfizer who sought cyclic amidines with suitable pharmacokinetic properties (specifically, duration of action) for use...
Approved
Vet approved
Matched Salts cas: … 22204-24-6 …
Matched Products: … ASKOL ÇIĞNEME TABLETI, 6 ADET ... KONTIL 250 MG ÇİĞNEME TABLETİ, 6 ADET …
Matched Products: … ASKOL ÇIĞNEME TABLETI, 6 ADET ... KONTIL 250 MG ÇİĞNEME TABLETİ, 6 ADET …
Imiquimod
Imiquimod is an immune response modifier that acts as a toll-like receptor 7 agonist. Imiquimod is commonly used topically to treat warts on the skin of the genital and anal areas. Imiquimod does not cure warts, and new warts may appear during treatment. Imiquimod does not fight the viruses that...
Approved
Investigational
Matched Products: … ALDARA %5 KREM, 6 SAŞE …
Tiaprofenic acid
Tiaprofenic acid is a non-steroidal anti-inflammatory drug employed in the treatment of pain, particularly arthritis pain. It belongs to the arylpropionic acid (profen) group of nonsteroidal anti-inflammatory drugs (NSAIDs).
Approved
Matched Products: … SURGAM 300 MG SUPOZITUVAR, 6 ADET …
Dyphylline
Dyphylline is a theophylline derivative with broncho- and vasodilator properties. It is typically used in the management of asthma, cardiac dyspnea, and bronchitis.
Approved
Matched Products: … ENJEKSİYONLUK ÇÖZELTİ, 6 AMPUL …
Lixisenatide
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type II diabetes mellitus (T2DM). It is sold by Sanofi-Aventis under the brand name Adlyxin in the US and Lyxumia in the EU. Adlyxin recieved FDA approval July 28, 2016.
Approved
Matched Products: … LYXUMIA 20 MCG ENJEKSIYON IÇIN ÇÖZELTI IÇEREN KULLANIMA HAZIR KALEM ,6 KALEM …
Padeliporfin
Padeliporfin is a water-soluble chlorophyll derivative and cytotoxic photosensitizer used for vascular-targeted photodynamic therapy for malignancies. Vascular-targeted photodynamic therapy (VTP), or vascular targeted photochemotherapy, is a focal treatment for localized prostate cancer. It aims to destroy only cancerous lesions of the prostate, rather than ablating the entire prostate gland. Padeliporfin...
Approved
Experimental
Streptococcus pneumoniae type 9n capsular polysaccharide antigen
Streptococcus pneumoniae type 9n capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 9n of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
Approved
Investigational
Matched Mixtures name: … Pneumovax 23 ... Pneumovax 23 ... Pneumovax 23 …
Streptococcus pneumoniae type 15b capsular polysaccharide antigen
Streptococcus pneumoniae type 15b capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 15b of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
Approved
Investigational
Matched Mixtures name: … Pneumovax 23 ... Pneumovax 23 ... Pneumovax 23 …
Displaying drugs 76 - 100 of 4712 in total